MSX-127 25 mg | 99.61%
TargetMol
MSX-127
Search Results
MSX-127 5 mg | 99.61%
TargetMol
MSX-127
DprE1-IN-2 10 mg | 99.91%
TargetMol
DprE1-IN-2
Sulfatinib 25 mg | 98.93%
TargetMol
Sulfatinib (HMPL-012) is a potent and highly selective tyrosine kinase inhibitor against VEGFR1/2/3, FGFR1 and CSF1R with IC 50 s ranging from 1 to 24 nM.
More Information Supplier PageSulfatinib
Sulfatinib 1 mg | 98.93%
TargetMol
Sulfatinib (HMPL-012) is a potent and highly selective tyrosine kinase inhibitor against VEGFR1/2/3, FGFR1 and CSF1R with IC 50 s ranging from 1 to 24 nM.
More Information Supplier PageSulfatinib
Sulfatinib 10 mg | 98.93%
TargetMol
Sulfatinib (HMPL-012) is a potent and highly selective tyrosine kinase inhibitor against VEGFR1/2/3, FGFR1 and CSF1R with IC 50 s ranging from 1 to 24 nM.
More Information Supplier PageSulfatinib
DprE1-IN-2 5 mg | 99.91%
TargetMol
DprE1-IN-2
DprE1-IN-2 50 mg | 99.91%
TargetMol
DprE1-IN-2
DprE1-IN-2 2 mg | 99.91%
TargetMol
DprE1-IN-2
Gracillin 10 mg | Purity Not Available
TargetMol
Gracillin can induce cell cycle arrest, oxidative stress, and apoptosis in HL60 cells, and has the potential to be developed as an antitumor agent. Gracillin can be selected as lead compounds for the development of new drugs against I. multifiliis.
More Information Supplier PageGracillin
